8 studies found for:    (NCCAM) [SPONSOR-COLLABORATORS] (hepatitis) [CONDITION]
Show Display Options
Rank Status Study
1 Completed IdB 1016 Treatment for Hepatitis C Disease
Condition: Hepatitis C, Chronic
Intervention: Drug: IdB 1016
2 Withdrawn Treatment of Alcohol-Related Hepatitis With Arginine
Condition: Alcoholic Hepatitis
Intervention: Drug: Arginine
3 Completed Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment
Condition: Chronic Hepatitis C
Interventions: Drug: Silymarin;   Other: Placebo
4 Completed Evaluating Silymarin for Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Drug: Silymarin (milk thistle)
5 Completed Herbal Treatment of Hepatitis C in Methadone Maintained Patients
Condition: Hepatitis C
Intervention: Drug: Herbal remedies
6 Completed Phase I Trial of Silymarin for Chronic Liver Diseases
Conditions: Hepatitis C;   Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Placebo;   Drug: Silymarin
7 Withdrawn Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health Outcomes
Condition: Hepatitis C
Intervention: Drug: Interferon-alpha
8 Completed Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   Oxidative Stress
Interventions: Drug: silymarin;   Dietary Supplement: green tea extract (EGCG)

Indicates status has not been verified in more than two years